Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy P Cripe

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Oncotarget|November 16, 2017
Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapyKellie B Haworth, Michael A Arnold, Christopher R Pierson, et al.
Molecular Therapy. Oncology|March 2, 2026
Trabectedin decreases myeloid resistance to improve the efficacy of anti-PD1 immunotherapy and delay glioma malignant progressionMatthew Nazzaro, Elaine R Mardis, Alessandro Canella, et al.
Molecular Therapy. Oncology|December 25, 2024
Employing splice-switching oligonucleotides and AAVrh74.U7 snRNA to target insulin receptor splicing and cancer hallmarks in osteosarcomaSafiya Khurshid, Akila S Venkataramany, Matias Montes, et al.
Scientific Reports|May 26, 2017
Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma ModelsChun-Yu Chen, Pin-Yi Wang, Brian Hutzen, et al.
Molecular Therapy Oncolytics|October 26, 2019
Immunotherapeutic Challenges for Pediatric CancersBrian Hutzen, Mohammed Ghonime, Joel Lee, et al.
Frontiers in Immunology|July 7, 2020
A Novel Pathogenic Variant in <i>CARMIL2</i> (<i>RLTPR</i>) Causing CARMIL2 Deficiency and EBV-Associated Smooth Muscle TumorsJennifer R Yonkof, Ajay Gupta, Cesar M Rueda, et al.
Pediatric Blood & Cancer|November 18, 2015
Characterization of MHC Class I and β-2-Microglobulin Expression in Pediatric Solid Malignancies to Guide Selection of Immune-Based Therapeutic TrialsKellie B Haworth, Michael A Arnold, Christopher R Pierson, et al.
International Journal of Cancer|October 18, 2019
GD2-directed CAR-T cells in combination with HGF-targeted neutralizing antibody (AMG102) prevent primary tumor growth and metastasis in Ewing sarcomaManish Charan, Piyush Dravid, Maren Cam, et al.
Pediatric Blood & Cancer|February 15, 2011
Preclincial testing of sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imagingJianqiang Wu, Eva Dombi, Edwin Jousma, et al.
Molecular Cancer Therapeutics|May 17, 2008
Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumorsGunnar Johansson, Yonatan Y Mahller, Margaret H Collins, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Oncotarget|November 16, 2017
Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapyKellie B Haworth, Michael A Arnold, Christopher R Pierson, et al.
Molecular Therapy. Oncology|March 2, 2026
Trabectedin decreases myeloid resistance to improve the efficacy of anti-PD1 immunotherapy and delay glioma malignant progressionMatthew Nazzaro, Elaine R Mardis, Alessandro Canella, et al.
Molecular Therapy. Oncology|December 25, 2024
Employing splice-switching oligonucleotides and AAVrh74.U7 snRNA to target insulin receptor splicing and cancer hallmarks in osteosarcomaSafiya Khurshid, Akila S Venkataramany, Matias Montes, et al.
Scientific Reports|May 26, 2017
Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma ModelsChun-Yu Chen, Pin-Yi Wang, Brian Hutzen, et al.
Molecular Therapy Oncolytics|October 26, 2019
Immunotherapeutic Challenges for Pediatric CancersBrian Hutzen, Mohammed Ghonime, Joel Lee, et al.
Frontiers in Immunology|July 7, 2020
A Novel Pathogenic Variant in <i>CARMIL2</i> (<i>RLTPR</i>) Causing CARMIL2 Deficiency and EBV-Associated Smooth Muscle TumorsJennifer R Yonkof, Ajay Gupta, Cesar M Rueda, et al.
Pediatric Blood & Cancer|November 18, 2015
Characterization of MHC Class I and β-2-Microglobulin Expression in Pediatric Solid Malignancies to Guide Selection of Immune-Based Therapeutic TrialsKellie B Haworth, Michael A Arnold, Christopher R Pierson, et al.
International Journal of Cancer|October 18, 2019
GD2-directed CAR-T cells in combination with HGF-targeted neutralizing antibody (AMG102) prevent primary tumor growth and metastasis in Ewing sarcomaManish Charan, Piyush Dravid, Maren Cam, et al.
Pediatric Blood & Cancer|February 15, 2011
Preclincial testing of sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imagingJianqiang Wu, Eva Dombi, Edwin Jousma, et al.
Molecular Cancer Therapeutics|May 17, 2008
Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumorsGunnar Johansson, Yonatan Y Mahller, Margaret H Collins, et al.
Pageof 13